Somewhat Negative Press Coverage Somewhat Unlikely to Impact Syneron Medical (ELOS) Stock Price
News articles about Syneron Medical (NASDAQ:ELOS) have trended somewhat negative recently, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Syneron Medical earned a coverage optimism score of -0.03 on Accern’s scale. Accern also gave news headlines about the medical equipment provider an impact score of 46.5358445829728 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Shares of Syneron Medical (NASDAQ ELOS) opened at $11.00 on Monday. Syneron Medical has a 1 year low of $6.18 and a 1 year high of $11.43.
About Syneron Medical
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.
Receive News & Ratings for Syneron Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical and related companies with Analyst Ratings Network's FREE daily email newsletter.